There is some common confusion about FDA approval of Regenexx as a result of reports about our case against the FDA the last few years. That case relates only to the Regenexx C procedure, which is different from any Regenexx procedures now being performed in the United States.
Because our procedures supplement natural healing, early activity is strongly encouraged. Wait times are dependent on the type of procedure performed.
If there is minimal cartilage loss and in the case of a partial tendon / ligament / muscle tear, low-impact activities are encouraged immediately after the procedure. Full high-impact activities are expected within four to six weeks of the procedure.
In the case of a partial tendon / ligament / muscle tear, low-impact activities would be encouraged immediately after the procedure. Full high-impact activities would be expected at four to six weeks.
Bone-healing Procedures (for fracture non-union or avascular necrosis)
In these cases, patients are required to refrain from using the injured body part until the pain from the procedure subsides. They then can then begin slowly increasing activities over the next few weeks. This healing process typically takes one to three weeks, with normal activity resuming at about six weeks. The only exception is when there is an existing rod or plate stabilizing the fracture site—in that case normal activity may be resumed more quickly.
- bone-marrow concentrate plus fat injections help knee arthritis function
- knee surgery with concentrated bone-marrow cells produces better results than knee surgery alone
- injectable MSCs helps cartilage-repair scores in patients undergoing HTO surgery
- meniscus repair in the red-white zone
- microfracture plus bone-marrow concentrate for cartilage repair
- knee osteochondral lesion stem-cell concentrate plus HA
- concentrated bone-marrow stem cells plus microfracture better than microfracture alone
- bone-marrow concentrate plus microfracture stimulates successful cartilage repair in focal lesions…
- mesenchymal stem cells plus hyaluronic acid used with knee microfracture surgery
- bone-marrow concentrate plus bioscaffold for larger knee-cartilage lesions
- arthroscopic surgery plus bone-marrow concentrate produces better cartilage repair on MRI than control images
- cultured bone-marrow stem-cell injections indicate better quality cartilage on follow-up MRIs
- assorted articles at National Library of Medicine on mesenchymal stem cells and cartilage repair
- one-step bone-marrow-derived cell transplantation in talar osteochondral lesions
- knee arthritis treated with HTO and microfracture plus stem cells
- clinical studies of cartilage repair using bone-marrow concentrates and cultured bone-marrow stem cells
- osteonecrosis of the femoral head
- study on AVN of the hip
- one of the original studies on using bone-marrow stem cells for AVN of the hip (1990s)
- hip osteoarthritis
building new blood vessels
- bone-marrow concentrate improves hip-fracture healing
- bone-marrow concentrate improves sinus-surgery-implant survival rates
- bone-marrow concentrate helps non-union fractures heal
- promoting spinal fusion
- fracture healing
- fracture healing (pseudo-arthrosis)
- fracture non-union
- bone-marow stem cell stimulate healing of non-healing fractures
- bone-marrow stem cells dramatically improve rotator cuff healing at 10 year follow-up
- marrow-nucleated cells work as well as cultured cells for tendon repair
- equine model